Flow Cytometric Detection of the Classical Hodgkin Lymphoma: Clinical and Research Applications

por Roshal, Mikhail, Wood, Brent L., Fromm, Jonathan R.
Publicado 2011

Ultrasensitive detection of acute myeloid leukemia minimal residual disease using single molecule molecular inversion probes

por Waalkes, Adam, Penewit, Kelsi, Wood, Brent L., Wu, David, Salipante, Stephen J.
Publicado 2017

Detection of minimal residual disease in NPM1-mutated acute myeloid leukemia by next-generation sequencing

por Salipante, Stephen J., Fromm, Jonathan R., Shendure, Jay, Wood, Brent L., Wu, David
Publicado 2014

Impact of Blinatumomab Treatment on Bone Marrow Function in Patients with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia

por Kantarjian, Hagop M., Zugmaier, Gerhard, Brüggemann, Monika, Wood, Brent L., Horst, Heinz A., Zeng, Yi, Martinelli, Giovanni
Publicado 2021

Impact of Minimal Residual Disease, Detected by Flow Cytometry, on Outcome of Myeloablative Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia

por Bar, Merav, Wood, Brent L., Radich, Jerald P., Doney, Kristine C., Woolfrey, Ann E., Delaney, Colleen, Appelbaum, Frederick R., Gooley, Ted A.
Publicado 2014

Effect of Measurable (“Minimal”) Residual Disease (MRD) Information on Prediction of Relapse and Survival in Adult Acute Myeloid Leukemia

por Othus, Megan, Wood, Brent L., Stirewalt, Derek L., Estey, Elihu H., Petersdorf, Stephen H., Appelbaum, Frederick R., Erba, Harry P., Walter, Roland B.
Publicado 2016

Relative impact of residual cytogenetic abnormalities and flow cytometric measurable residual disease on outcome after allogeneic hematopoietic cell transplantation in adult acute...

por Orvain, Corentin, Wilson, Jacob A., Fang, Min, Sandmaier, Brenda M., Rodríguez-Arbolí, Eduardo, Wood, Brent L., Othus, Megan, Appelbaum, Frederick R., Walter, Roland B.
Publicado 2022

Pre- and Post-Transplant Quantification of Measurable (“Minimal”) Residual Disease via Multiparameter Flow Cytometry in Adult Acute Myeloid Leukemia

por Zhou, Yi, Othus, Megan, Araki, Daisuke, Wood, Brent L., Radich, Jerald P., Halpern, Anna B., Mielcarek, Marco, Estey, Elihu H., Appelbaum, Frederick R., Walter, Roland B.
Publicado 2016

VpreB surrogate light chain expression in B-lineage ALL: a report from the Children’s Oncology Group

por Winter, Stuart S., McCaustland, Amanda, Qu, Chunxu, Simeona, No’eau, Heerema, Nyla A., Carroll, Andrew J., Wood, Brent L., Gheorghe, Gabriela, Mullighan, Charles G., Wilson, Bridget S.
Publicado 2022

Comparison of Minimal Residual Disease as Outcome Predictor for AML Patients in First Complete Remission Undergoing Myeloablative or Nonmyeloablative Allogeneic Hematopoietic Cell...

por Walter, Roland B., Gyurkocza, Boglarka, Storer, Barry E., Godwin, Colin D., Pagel, John M., Buckley, Sarah A., Sorror, Mohamed L., Wood, Brent L., Storb, Rainer, Appelbaum, Frederick R., Sandmaier, Brenda M.
Publicado 2014

Impact of Pre-Transplant Measurable Residual Disease on Outcome of Allogeneic Hematopoietic Cell Transplantation in Adult Monosomal Karyotype AML

por Morsink, Linde M., Othus, Megan, Bezerra, Evandro D., Wood, Brent L., Fang, Min, Sandmaier, Brenda M., Mielcarek, Marco, Schoch, Gary, Storb, Rainer, Joachim Deeg, H., Appelbaum, Frederick R., Walter, Roland B.
Publicado 2020

CD22(low)/Bcl-2(high) expression identifies poor response to inotuzumab ozogamicin in relapsed/refractory acute lymphoblastic leukemia

por Wintering, Astrid, Ishiyama, Kenichi, Tamaki, Stanley, Tamaki, Courtney, Fandel, Joshua, Ji, Lingyun, Wood, Brent L., Shah, Nirali N., Yuan, Constance M., O’Brien, Maureen M., Loh, Mignon L., Diaz-Flores, Ernesto
Publicado 2022

Outcomes after late bone marrow and very early central nervous system relapse of childhood B-acute lymphoblastic leukemia: a report from the Children’s Oncology Group phase III stu...

por Lew, Glen, Chen, Yichen, Lu, Xiaomin, Rheingold, Susan R., Whitlock, James A., Devidas, Meenakshi, Hastings, Caroline A., Winick, Naomi J., Carroll, William L., Wood, Brent L., Borowitz, Michael J., Pulsipher, Michael A., Hunger, Stephen P.
Publicado 2020

Minimal residual disease prior to allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a meta-analysis

por Buckley, Sarah A., Wood, Brent L., Othus, Megan, Hourigan, Christopher S., Ustun, Celalettin, Linden, Michael A., DeFor, Todd E., Malagola, Michele, Anthias, Chloe, Valkova, Veronika, Kanakry, Christopher G., Gruhn, Bernd, Buccisano, Francesco, Devine, Beth, Walter, Roland B.
Publicado 2017

Inhibition of the Sec61 translocon overcomes cytokine‐induced glucocorticoid resistance in T‐cell acute lymphoblastic leukaemia

por Meyer, Lauren K., Delgado‐Martin, Cristina, Sharp, Phillip P., Huang, Benjamin J., McMinn, Dustin, Vincent, Tiffaney L., Ryan, Theresa, Horton, Terzah M., Wood, Brent L., Teachey, David T., Taunton, Jack, Kirk, Christopher J., Hermiston, Michelle L.
Publicado 2022

Conditioning Intensity, Pre-Transplant Flow Cytometric Measurable Residual Disease, and Outcome in Adults with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Trans...

por Morsink, Linde M., Sandmaier, Brenda M., Othus, Megan, Palmieri, Raffaele, Granot, Noa, Bezerra, Evandro D., Wood, Brent L., Mielcarek, Marco, Schoch, Gary, Davis, Chris, Flowers, Mary E. D., Deeg, H. Joachim, Appelbaum, Frederick R., Storb, Rainer, Walter, Roland B.
Publicado 2020

Technical Aspects of Flow Cytometry-based Measurable Residual Disease Quantification in Acute Myeloid Leukemia: Experience of the European LeukemiaNet MRD Working Party

por Tettero, Jesse M., Freeman, Sylvie, Buecklein, Veit, Venditti, Adriano, Maurillo, Luca, Kern, Wolfgang, Walter, Roland B., Wood, Brent L., Roumier, Christophe, Philippé, Jan, Denys, Barbara, Jorgensen, Jeffrey L., Bene, Marie C., Lacombe, Francis, Plesa, Adriana, Guzman, Monica L., Wierzbowska, Agnieszka, Czyz, Anna, Ngai, Lok Lam, Schwarzer, Adrian, Bachas, Costa, Cloos, Jacqueline, Subklewe, Marion, Fuering-Buske, Michaela, Buccisano, Francesco
Publicado 2021

AML risk stratification models utilizing ELN-2017 guidelines and additional prognostic factors: a SWOG report

por Pogosova-Agadjanyan, Era L., Moseley, Anna, Othus, Megan, Appelbaum, Frederick R., Chauncey, Thomas R., Chen, I-Ming L., Erba, Harry P., Godwin, John E., Jenkins, Isaac C., Fang, Min, Huynh, Mike, Kopecky, Kenneth J., List, Alan F., Naru, Jasmine, Radich, Jerald P., Stevens, Emily, Willborg, Brooke E., Willman, Cheryl L., Wood, Brent L., Zhang, Qing, Meshinchi, Soheil, Stirewalt, Derek L.
Publicado 2020

PRC2 loss induces chemoresistance by repressing apoptosis in T cell acute lymphoblastic leukemia

por Ariës, Ingrid M., Bodaar, Kimberly, Karim, Salmaan A., Chonghaile, Triona Ni, Hinze, Laura, Burns, Melissa A., Pfirrmann, Maren, Degar, James, Landrigan, Jack T., Balbach, Sebastian, Peirs, Sofie, Menten, Björn, Isenhart, Randi, Stevenson, Kristen E., Neuberg, Donna S., Devidas, Meenakshi, Loh, Mignon L., Hunger, Stephen P., Teachey, David T., Rabin, Karen R., Winter, Stuart S., Dunsmore, Kimberly P., Wood, Brent L., Silverman, Lewis B., Sallan, Stephen E., Van Vlierberghe, Pieter, Orkin, Stuart H., Knoechel, Birgit, Letai, Anthony G., Gutierrez, Alejandro
Publicado 2018

MLL Rearrangements Impact Outcome in HOXA-deregulated T-lineage Acute Lymphoblastic Leukemia: A Children's Oncology Group Study

por Matlawska-Wasowska, Ksenia, Kang, Huining, Devidas, Meenakshi, Wen, Ji, Harvey, Richard C., Nickl, Christian K., Ness, Scott A., Rusch, Michael, Li, Yongjin, Onozawa, Masahiro, Martinez, Carmen, Wood, Brent L., Asselin, Barbara L., Chen, I-Ming, Roberts, Kathryn G., Baruchel, André, Soulier, Jean, Dombret, Hervé, Zhang, Jinghui, Larson, Richard S., Raetz, Elizabeth A., Carroll, William L., Winick, Naomi J., Aplan, Peter D., Loh, Mignon L., Mullighan, Charles G., Hunger, Stephen P., Heerema, Nyla A., Carroll, Andrew J., Dunsmore, Kimberly P., Winter, Stuart S.
Publicado 2016